Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.730
-0.010 (-0.57%)
At close: Mar 9, 2026, 4:00 PM EDT
1.760
+0.030 (1.73%)
After-hours: Mar 9, 2026, 4:52 PM EDT
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$1,361
Profits / Employee
-$806,660
Market Cap
118.86M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 188 |
| Gossamer Bio | 145 |
| Precision BioSciences | 67 |
| Cardiff Oncology | 31 |
| Oncolytics Biotech | 28 |
| Gain Therapeutics | 25 |
| Genelux | 24 |
| Black Diamond Therapeutics | 24 |
INO News
- 9 hours ago - INOVIO to Participate in Upcoming Scientific Conferences - PRNewsWire
- 4 days ago - INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - PRNewsWire
- 5 days ago - Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) - PRNewsWire
- 5 days ago - INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) - PRNewsWire
- 12 days ago - Inovio Pharmaceuticals, Inc. (INO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript - Seeking Alpha
- 25 days ago - INOVIO to Participate in Upcoming Scientific and Investor Conferences - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 - Seeking Alpha
- 2 months ago - FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) - PRNewsWire